APRIL (AbatacePt in Rheumatoid Arthritis-ILD)

计划入组 30 人 · 首次发布于 2017 年 3 月 21 日

Pilot Guaranteed Income Study, Philadelphia, April 2023

计划入组 100 人 · 首次发布于 2023 年 5 月 1 日

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

计划入组 176 人 · 首次发布于 2023 年 3 月 22 日

APRIL chimeric antigen receptor-T cell therapy (Yake Biotechnology)

Bicephali anti-APRIL/anti-BAFF CAR T-cell therapy (lentiviral vector, multiple myeloma)

Agarwal, Dr Anil

Canada

Long Non-coding RNAs Emerge as Key Regulators of Vascular Endothelium and Angiogenesis

FDA Approves First Bispecific T-Cell Engager for Solid Tumors and Expands Indications for Immunotherapies

Qlife's Egoo Health Platform Shows Promise in PKU Monitoring and CRP Testing Amidst Restructuring